Cargando…
Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model
The poor prognosis in non-small-cell lung cancer has driven the development of novel targeted therapies. Vascular endothelial growth factor is the most potent force in mediating tumor angiogenesis, and many angiogenesis inhibitors have been developed for oncology treatment. We performed a study to c...
Autores principales: | Jin, Yinghua, Wei, Lingxiao, Jiang, Qiuying, Song, Xiaowei, Teng, Chong, Fan, Chengjuan, Lv, Yanju, Liu, Ying, Shen, Weixi, Li, Li, Huang, Dayong, Xin, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203857/ https://www.ncbi.nlm.nih.gov/pubmed/30367145 http://dx.doi.org/10.1038/s41598-018-34030-5 |
Ejemplares similares
-
Landscape of associations between long non‐coding RNAs and infiltrating immune cells in liver hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2020) -
Endostar Plus Apatinib Successfully Achieved Long Term Progression-Free Survival in Refractory Ovarian Cancer: A Case Report and Literature Review
por: Xiao, Chunmei, et al.
Publicado: (2021) -
Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers
por: Chen, Weijie, et al.
Publicado: (2011) -
Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma
por: Wang, Yang, et al.
Publicado: (2018) -
The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma
por: Guan, Ying, et al.
Publicado: (2015)